210 related articles for article (PubMed ID: 1323732)
1. Solid-phase extraction and HPLC-UV confirmation of drugs of abuse in urine.
Ferrara SD; Tedeschi L; Frison G; Castagna F
J Anal Toxicol; 1992; 16(4):217-22. PubMed ID: 1323732
[TBL] [Abstract][Full Text] [Related]
2. ONTRAK TESTCUP: a novel, on-site, multi-analyte screen for the detection of abused drugs.
Towt J; Tsai SC; Hernandez MR; Klimov AD; Kravec CV; Rouse SL; Subuhi HS; Twarowska B; Salamone SJ
J Anal Toxicol; 1995 Oct; 19(6):504-10. PubMed ID: 8926746
[TBL] [Abstract][Full Text] [Related]
3. Determination of five abused drugs in nitrite-adulterated urine by immunoassays and gas chromatography-mass spectrometry.
Tsai SC; ElSohly MA; Dubrovsky T; Twarowska B; Towt J; Salamone SJ
J Anal Toxicol; 1998 Oct; 22(6):474-80. PubMed ID: 9788522
[TBL] [Abstract][Full Text] [Related]
4. Comparison of RapiTest with Emit d.a.u. and GC-MS for the analysis of drugs in urine.
Korte T; Pykäläinen J; Lillsunde P; Seppälä T
J Anal Toxicol; 1997; 21(1):49-53. PubMed ID: 9013293
[TBL] [Abstract][Full Text] [Related]
5. Recreational drug use at a major music festival: trend analysis of anonymised pooled urine.
Hoegberg LCG; Christiansen C; Soe J; Telving R; Andreasen MF; Staerk D; Christrup LL; Kongstad KT
Clin Toxicol (Phila); 2018 Apr; 56(4):245-255. PubMed ID: 28814125
[TBL] [Abstract][Full Text] [Related]
6. The analytical performance of six urine drug screens on cobas 6000 and ARCHITECT i2000 compared to LC-MS/MS gold standard.
Abou El Hassan M; Colantonio D; Likhodii S; Nassar BA
Clin Biochem; 2021 Jul; 93():99-103. PubMed ID: 33844982
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of an Automated Reader and Color Interpretation-Based Immunoassays for Multiplexed Drug-of-Abuse Testing in Urine.
Kim SY; Kim H; Park Y; Lim J; Kim J; Koo SH; Kwon GC
J Anal Toxicol; 2017 Jun; 41(5):412-420. PubMed ID: 28201761
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of multiple drugs of abuse and relevant metabolites in urine by LC-MS-MS.
Feng J; Wang L; Dai I; Harmon T; Bernert JT
J Anal Toxicol; 2007 Sep; 31(7):359-68. PubMed ID: 17725883
[TBL] [Abstract][Full Text] [Related]
9. A Retrospective Analysis of Urine Drugs of Abuse Immunoassay True Positive Rates at a National Reference Laboratory.
Johnson-Davis KL; Sadler AJ; Genzen JR
J Anal Toxicol; 2016 Mar; 40(2):97-107. PubMed ID: 26668238
[TBL] [Abstract][Full Text] [Related]
10. Detection of drugs of abuse in exhaled breath from users following recovery from intoxication.
Beck O; Stephanson N; Sandqvist S; Franck J
J Anal Toxicol; 2012; 36(9):638-46. PubMed ID: 23045289
[TBL] [Abstract][Full Text] [Related]
11. Drug of abuse confirmation in human urine using stepwise solid-phase extraction and micellar electrokinetic capillary chromatography.
Wernly P; Thormann W
Anal Chem; 1992 Sep; 64(18):2155-9. PubMed ID: 1416050
[TBL] [Abstract][Full Text] [Related]
12. Rapid reversed-phase high-performance liquid chromatographic method for the assay of urinary 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid and confirmation of use of cannabis derivatives.
Bianchi V; Donzelli G
J Chromatogr B Biomed Appl; 1996 Jan; 675(1):162-7. PubMed ID: 8634759
[TBL] [Abstract][Full Text] [Related]
13. Zinc reduces the detection of cocaine, methamphetamine, and THC by ELISA urine testing.
Venkatratnam A; Lents NH
J Anal Toxicol; 2011 Jul; 35(6):333-40. PubMed ID: 21740689
[TBL] [Abstract][Full Text] [Related]
14. Identification and quantitation of drugs of abuse in urine using the generalized rank annihilation method of curve resolution.
Li S; Gemperline PJ; Briley K; Kazmierczak S
J Chromatogr B Biomed Appl; 1994 May; 655(2):213-23. PubMed ID: 8081467
[TBL] [Abstract][Full Text] [Related]
15. Analysis of cocaine, benzoylecgonine, and cocaethylene in urine by HPLC with diode array detection.
Clauwaert KM; Van Bocxlaer JF; Lambert WE; De Leenheer AP
Anal Chem; 1996 Sep; 68(17):3021-8. PubMed ID: 8794932
[TBL] [Abstract][Full Text] [Related]
16. A method for the confirmation and identification of drugs of misuse in urine using solid phase extraction and gas-liquid chromatography with mass spectrometry.
Galloway JH; Ashford M; Marsh ID; Holden M; Forrest AR
J Clin Pathol; 1998 Apr; 51(4):326-9. PubMed ID: 9659249
[TBL] [Abstract][Full Text] [Related]
17. Analysis of drugs of abuse in urine by gas chromatography/mass spectrometry: experience and application.
Karacić V; Skender L
Arh Hig Rada Toksikol; 2000 Dec; 51(4):389-400. PubMed ID: 11276966
[TBL] [Abstract][Full Text] [Related]
18. Reducing false-negative tests in urinary drugs-of-abuse screening.
Luceri F; Godi F; Messeri G
J Anal Toxicol; 1997; 21(3):244-5. PubMed ID: 9171214
[No Abstract] [Full Text] [Related]
19. Confirmatory tests for drugs in the workplace by gas chromatography-mass spectrometry.
Goldberger BA; Cone EJ
J Chromatogr A; 1994 Jul; 674(1-2):73-86. PubMed ID: 8075776
[TBL] [Abstract][Full Text] [Related]
20. High-performance liquid chromatographic confirmation of cocaine and benzoylecgonine in biological samples using photodiode-array detection after toxicological screening.
Balíková M; Vecerková J
J Chromatogr B Biomed Appl; 1994 Jun; 656(1):267-73. PubMed ID: 7952039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
